RxDoctor Payments DataLook up a doctor →

Christopher Pieczonka, MD

Urology · Syracuse, NYNPI 1376530121

Payments from drug & device makers

$31,221,199in general payments, 2019–2025

Across 3,760 payments — averaging $8303.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medivation LLC.$9.6M
  • Pfizer$8.6M
  • Janssen Research & Development, LLC$5.1M
  • Merck$4.3M
  • AstraZeneca$698K
  • Dendreon Pharmaceuticals LLC$643K
  • plus $2.3M from 54 others
$70,824in research payments, 2019–2025

Across 62 payments — averaging $1142.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dendreon Pharmaceuticals LLC$50K
  • Pfizer$12K
  • Eli Lilly$6K
  • Astellas Pharma Global Development$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medivation LLC.876$9,589,496
Pfizer567$8,583,523
Janssen Research & Development, LLC585$5,116,815
Merck290$4,284,018
AstraZeneca76$698,329
Dendreon Pharmaceuticals LLC232$642,632
Bayer254$494,660
Eli Lilly22$319,877
Sumitomo Pharma America, Inc.87$309,422
Johnson & Johnson(2 entities)236$208,625
E.r. Squibb & Sons, L.L.C.5$156,759
Astrazeneca UK Limited3$142,451
Teleflex LLC5$105,989
Astellas Pharma US Inc129$96,869
Myovant Sciences Inc.24$84,743
Immunitybio, Inc.25$76,687
Astellas Pharma Global Development17$62,511
Veru Inc.17$34,835
Sun Pharmaceutical Industries Inc.38$34,833
Epizyme, Inc.12$33,255
Bristol Myers Squibb1$30,500
Ferring Pharmaceuticals AS8$24,907
Progenics Pharmaceuticals, Inc.4$20,450
Novartis20$18,508
Boston Scientific6$12,102
Ferring Pharmaceuticals Inc.25$7,084
Tolmar Pharmaceuticals, Inc.17$6,462
Urogen Pharma, Inc.14$3,465
Urovant Sciences Inc5$2,331
Telix Pharmaceuticals15$2,174
Lilly USA, LLC1$2,100
Janssen Scientific Affairs, LLC9$2,098
Blue Earth Diagnostics2$1,720
Daiichi Sankyo Inc.1$1,650
Exelixis Inc.1$1,470
Janssen Global Services, LLC2$1,437
AbbVie(2 entities)7$1,247
Foundation Medicine, Inc.2$829
Myriad Genetic Laboratories, Inc.20$768
Accord Healthcare, Inc.18$624
Medtronic(2 entities)5$622
Palette Life Sciences, Inc.5$342
Neotract Inc.6$296
Coloplast13$263
Amgen11$217
180 Medical, Inc.7$144
Histosonics, Inc.1$142
Procept Biorobotics Corporation1$136
Siemens Medical Solutions USA, Inc.1$125
C. R. Bard, Inc. & Subsidiaries2$98
Olympus America Inc.4$86
Endo Pharmaceuticals Inc.4$82
Verity Pharmaceuticals Inc.4$70
Antares Pharma, Inc.2$54
Endo USA, Inc.2$39
Bioprotect Medical, Inc.2$32
Laborie Medical Technologies Corp.1$30
Clarus Therapeutics Inc.2$29
Travere Therapeutics, Inc.2$26
Dentsply IH Inc.1$22

How this compares

$31,221,199 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024
$1,922,105
Medicare patients
1,125
Services billed
32,166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →